MiNK Therapeutics, Inc. (INKT)
9.57
-0.65
(-6.40%)
USD |
NASDAQ |
Nov 12, 16:00
9.57
0.00 (0.00%)
After-Hours: 18:59
MiNK Therapeutics EPS Diluted (Quarterly) : -0.6227 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6227 |
| March 31, 2026 | -0.5716 |
| December 31, 2025 | -0.5529 |
| September 30, 2025 | -0.6499 |
| June 30, 2025 | -1.064 |
| March 31, 2025 | -0.6978 |
| December 31, 2024 | -0.6227 |
| September 30, 2024 | -0.0457 |
| June 30, 2024 | -0.0727 |
| March 31, 2024 | -0.1101 |
| December 31, 2023 | -0.158 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.1483 |
| June 30, 2023 | -0.1801 |
| March 31, 2023 | -0.1674 |
| December 31, 2022 | -0.2298 |
| September 30, 2022 | -0.1876 |
| June 30, 2022 | -0.1818 |
| March 31, 2022 | -0.2321 |
| December 31, 2021 | -0.1722 |
| September 30, 2021 | -0.5894 |
| June 30, 2021 | -1.944 |
| March 31, 2021 | -0.118 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Vericel Corp. | 0.2674 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.128M |
| Total Expenses (Quarterly) | 3.128M |
| Enterprise Value | 43.30M |
| Earnings Yield | -25.05% |
| Normalized Earnings Yield | -25.62 |